IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
26.79
+0.19 (0.71%)
Nov 22, 2024, 4:00 PM EST - Market closed
IDEAYA Biosciences Analyst Ratings
Total Analysts
12
Consensus Rating
Strong Buy
Price Target
$53.67
Upside
+100.34%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stephens & Co. | Stephens & Co. | Buy Initiates $51 | Buy | Initiates | $51 | +90.37% | Nov 18, 2024 |
| Leerink Partners | Leerink Partners | Buy → Hold Downgrades $41 → $27 | Buy → Hold | Downgrades | $41 → $27 | +0.78% | Nov 5, 2024 |
| Oppenheimer | Oppenheimer | Buy Reiterates $53 | Buy | Reiterates | $53 | +97.84% | Oct 29, 2024 |
| UBS | UBS | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +86.64% | Oct 24, 2024 |
| Wedbush | Wedbush | Buy Maintains $54 → $52 | Buy | Maintains | $54 → $52 | +94.10% | Sep 24, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +127.70% | Sep 24, 2024 |
| Stifel | Stifel | Strong Buy Maintains $63 → $68 | Strong Buy | Maintains | $63 → $68 | +153.83% | Sep 10, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $60 → $58 | Strong Buy | Maintains | $60 → $58 | +116.50% | Aug 27, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $69 → $66 | Buy | Maintains | $69 → $66 | +146.36% | Aug 8, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $61 | Buy | Reiterates | $61 | +127.70% | Aug 7, 2024 |
| Wedbush | Wedbush | Buy Reiterates $54 | Buy | Reiterates | $54 | +101.57% | Aug 7, 2024 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $53 | Buy | Maintains | $60 → $53 | +97.84% | Aug 7, 2024 |
| JP Morgan | JP Morgan | Buy Maintains $65 → $69 | Buy | Maintains | $65 → $69 | +157.56% | Jul 12, 2024 |
| RBC Capital | RBC Capital | Buy Maintains $53 → $61 | Buy | Maintains | $53 → $61 | +127.70% | Jul 11, 2024 |
| BTIG | BTIG | Strong Buy Maintains $55 → $62 | Strong Buy | Maintains | $55 → $62 | +131.43% | Jul 9, 2024 |
| Stifel | Stifel | Strong Buy Maintains $63 | Strong Buy | Maintains | $63 | +135.16% | Jul 8, 2024 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.